Close

Jefferies Cuts Price Target on Immune Design (IMDZ) to $15 Following 3Q

Go back to Jefferies Cuts Price Target on Immune Design (IMDZ) to $15 Following 3Q

Immune Design (IMDZ) Tops Q3 EPS by 11c

November 9, 2016 4:48 PM EST

Immune Design (NASDAQ: IMDZ) reported Q3 EPS of ($0.60), $0.11 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $1.73 million.

For earnings history and earnings-related data on Immune Design (IMDZ) click here.

... More

Trading Radar for 11/9: Viacom (VIAB), Shake Shack (SHAK), TASER (TASR), Crocs (CROX), SunPower (SPWR) Report

November 8, 2016 3:12 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:

Earnings:

AdvancePierre Foods Holdings (Nasdaq: APFH) - consensus EPS $0.48
AgroFresh Solutions (Nasdaq: AGFS) - consensus EPS $0.12
Antares Pharma (Nasdaq: ATRS) - consensus loss $0.03
Arctic Cat (Nasdaq: ACAT) - consensus EPS $0.36
Barrett Business Services (Nasdaq: BBSI) - no Street consensus
Bellatrix Exploration (NYSE:... More